|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
Noel Doheny
Principal, Noel Doheny, LLC;
Former Chief Executive Officer, OpGen
|
| |
|
|
Mark Gibson
Director, Center for Evidence Based Policy
Oregon Health and Science University
|
| |
|
|
|
Anne Haddix
Chief Policy Officer, Office of Strategy and Innovation
Centers for Disease Control and Prevention (CDC)
|
| |
|
|
|
Andrea Lauber
Head, Technology Transactions for Clinical Biomarkers and Pharmacodiagnostics, Strategic Transactions Group
Bristol-Myers Squibb
|
| |
|
|
|
|
|
Elizabeth Mansfield, PhD
Director, Personalized Medicine, Office of In Vitro Diagnostics, Center for Devices and Radiological Health
FDA
|
| |
|
|
|
|
|
|
John Norris, JD, MBA
Former Chief Operating Officer, FDA;
Chairman and Chief Executive Officer, Norris Capital, Inc.
|
| |
|
|
|
Les D. Paul, MD, MS
Vice President, Clinical and Scientific Affairs
National Pharmaceutical Council
|
| |
|
|
|
David Rhew, MD
Vice President, Content Development and Client Services
Zynx Health
|
| |
|
|
|
|
|
|
|
Judy Zerzan, MD, MPH
Colorado Medicaid Medical Director
Colorado Department of Health Care Policy and Financing
|
| |
|
Printer Friendly
Email A Colleague
Bookmark Page
